Allegheny Financial Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
4,563
+224
+5% +$19.6K 0.04% 190
2026
Q1
$370K Buy
4,339
+24
+0.6% +$2.14K 0.05% 184
2025
Q4
$341K Buy
4,315
+16
+0.4% +$1.25K 0.05% 186
2025
Q3
$344K Buy
4,299
+9
+0.2% +$768 0.06% 180
2025
Q2
$390K Buy
4,290
+2,007
+88% +$183K 0.09% 161
2025
Q1
$214K Buy
2,283
+8
+0.4% +$716 0.05% 207
2024
Q4
$207K Buy
2,275
+7
+0.3% +$668 0.05% 217
2024
Q3
$235K Buy
2,268
+6
+0.3% +$612 0.06% 217
2024
Q2
$220K Buy
+2,262
New +$209K 0.06% 205

Other funds holding CL

Allegheny Financial Group's CL Position: Q2 2026 in Review

Allegheny Financial Group increased its Colgate-Palmolive (CL) stake by 5.2% in Q2 2026, buying an estimated $19.6K and bringing the position to 4,563 shares worth $418K. The position accounts for 0.04% of the portfolio, ranked #190.

Allegheny Financial Group first reported a position in CL in Q2 2024 and has held it in 9 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Allegheny Financial Group held 4,563 shares of Colgate-Palmolive worth $418K as of Q2 2026.
  • Allegheny Financial Group bought 224 Colgate-Palmolive shares in Q2 2026, an estimated $19.6K.
  • Colgate-Palmolive made up 0.04% of Allegheny Financial Group's portfolio in Q2 2026, its #190 holding.
  • Allegheny Financial Group first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.